Uncategorized

Avinger to Present at Oppenheimer Healthcare Conference on March 20Avinger to Present at Oppenheimer Healthcare Conference on March 20

Avinger to Present at Oppenheimer Healthcare Conference on March 20

REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments…

6 years ago
ITOCO – Camedco JV Creates Future Leader in Medical CannabisITOCO – Camedco JV Creates Future Leader in Medical Cannabis

ITOCO – Camedco JV Creates Future Leader in Medical Cannabis

TORONTO, ON / ACCESSWIRE / February 27, 2019 / Itoco Inc (OTC PINK: ITMC), has signed a letter of intent…

6 years ago
Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology SymposiumHeat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium

Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium

- Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment after tumor progression on prior…

6 years ago
New Paper Relevant for the Optimal Development of Drugs Targeting LSD1 Published by ORYZONNew Paper Relevant for the Optimal Development of Drugs Targeting LSD1 Published by ORYZON

New Paper Relevant for the Optimal Development of Drugs Targeting LSD1 Published by ORYZON

Uses proprietary chemoprobe technology to demonstrate target engagement, key to drug development and rational dosing Useful to identify interaction partners…

6 years ago
Evotec Receives Milestone Payment For Start Of Second Phase II Trial In Its Multi-Target Alliance With BayerEvotec Receives Milestone Payment For Start Of Second Phase II Trial In Its Multi-Target Alliance With Bayer

Evotec Receives Milestone Payment For Start Of Second Phase II Trial In Its Multi-Target Alliance With Bayer

PHASE II CLINICAL TRIAL ON PERSISTENT CHRONIC COUGH HAMBURG, GERMANY / ACCESSWIRE / February 28, 2019 / Evotec AG (OTC…

6 years ago
Theralase Named to 2019 TSX Venture 50(TM)Theralase Named to 2019 TSX Venture 50(TM)

Theralase Named to 2019 TSX Venture 50(TM)

Theralase Achieves Third Place in the Clean Technology and Life Sciences Category on the 2019 TSX Venture 50 TM TORONTO,…

6 years ago
EviTrade Provides Update on Hemp Based Extraction and Processing FacilityEviTrade Provides Update on Hemp Based Extraction and Processing Facility

EviTrade Provides Update on Hemp Based Extraction and Processing Facility

VANCOUVER, BC / ACCESSWIRE / February 28, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the ''Company'') provides…

6 years ago
Meet IKU DAO: The Company Prioritizing Drug Discovery By The ConsumersMeet IKU DAO: The Company Prioritizing Drug Discovery By The Consumers

Meet IKU DAO: The Company Prioritizing Drug Discovery By The Consumers

DALLAS, TX / ACCESSWIRE / February 26, 2019 / What if there was a way to prioritize drug discovery by…

6 years ago
MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque PsoriasisMorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis

MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / February 27, 2019 / MorphoSys AG (FSE: MOR) (NASDAQ: MOR) announced today that…

6 years ago
Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACROncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR

Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR

Data identifies a simple blood test that predicts clinical response to pelareorep CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE…

6 years ago